Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL

被引:60
|
作者
Muino, Elena [1 ]
Gallego-Fabrega, Cristina [1 ]
Cullell, Natalia [1 ]
Carrera, Caty [2 ]
Torres, Nuria [1 ]
Krupinski, Jurek [3 ]
Roquer, Jaume [4 ]
Montaner, Joan [2 ]
Fernandez-Cadenas, Israel [1 ]
机构
[1] Hosp Mutua Terrassa, Fundacio Docencia & Recerca Mutua Terrassa, Stroke Pharmacogen & Genet, Terrassa 08221, Spain
[2] Hosp Valle De Hebron, Neurovasc Res Lab, Vall dHebron Inst Res, Barcelona 08035, Spain
[3] Hosp Mutua Terrassa, Neurol Serv, Terrassa 08221, Spain
[4] Hosp Mar, IMIM, Inst Hosp Mar Invest Med, Neurol Serv, Barcelona 08003, Spain
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2017年 / 18卷 / 09期
关键词
CADASIL; cysteine; NOTCH3; mutation; temporal pole; AUTOSOMAL-DOMINANT ARTERIOPATHY; SUBCORTICAL INFARCTS; LEUKOENCEPHALOPATHY CADASIL; GENE; PATHOGENESIS; DIAGNOSIS; FAMILIES; RESIDUE; JAPAN; POLYMORPHISM;
D O I
10.3390/ijms18091964
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is caused by mutations in the NOTCH3 gene, affecting the number of cysteines in the extracellular domain of the receptor, causing protein misfolding and receptor aggregation. The pathogenic role of cysteine-sparing NOTCH3 missense mutations in patients with typical clinical CADASIL syndrome is unknown. The aim of this article is to describe these mutations to clarify if any could be potentially pathogenic. Articles on cysteine-sparing NOTCH3 missense mutations in patients with clinical suspicion of CADASIL were reviewed. Mutations were considered potentially pathogenic if patients had: (a) typical clinical CADASIL syndrome; (b) diffuse white matter hyperintensities; (c) the 33 NOTCH3 exons analyzed; (d) mutations that were not polymorphisms; and (e) Granular osmiophilic material (GOM) deposits in the skin biopsy. Twenty-five different mutations were listed. Four fulfill the above criteria: p.R61W; p.R75P; p.D80G; and p.R213K. Patients carrying these mutations had typical clinical CADASIL syndrome and diffuse white matter hyperintensities, mostly without anterior temporal pole involvement. Cysteine-sparing NOTCH3 missense mutations are associated with typical clinical CADASIL syndrome and typical magnetic resonance imaging (MRI) findings, although with less involvement of the anterior temporal lobe. Hence, these mutations should be further studied to confirm their pathological role in CADASIL.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Mutational Screening of NOTCH3 Gene Reveals Two Novel Mutations: Complexity of CADASIL Diagnosis
    Mosca, Lorena
    Rivieri, Francesca
    Tanel, Raffaella
    Bonfante, Aldo
    Burlina, Alessandro
    Manfredini, Emanuela
    Primignani, Paola
    Gesu, Giovanni P.
    Marocchi, Alessandro
    Penco, Silvana
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2014, 54 (04) : 723 - 729
  • [22] Two novel mutations of the NOTCH3 gene in Korean patients with CADASIL
    Kim, Y
    Kim, JS
    Kim, G
    No, YJ
    Yoo, HW
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 593 (1-2) : 116 - 120
  • [23] Prevalence and Atypical Clinical Characteristics of NOTCH3 Mutations Among Patients Admitted for Acute Lacunar Infarctions
    Okada, Takashi
    Washida, Kazuo
    Irie, Kenichi
    Saito, Satoshi
    Noguchi, Michio
    Tomita, Tsutomu
    Koga, Masatoshi
    Toyoda, Kazunori
    Okazaki, Shuhei
    Koizumi, Takashi
    Mizuta, Ikuko
    Mizuno, Toshiki
    Ihara, Masafumi
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [24] Targeted next generation sequencing identifies novel NOTCH3 gene mutations in CADASIL diagnostics patients
    Maksemous, Neven
    Smith, Robert A.
    Haupt, Larisa M.
    Griffiths, Lyn R.
    HUMAN GENOMICS, 2016, 10 : 1 - 12
  • [25] Microbleed clustering in thalamus sign in CADASIL patients with NOTCH3 R75P mutation
    Takei, Jun
    Higuchi, Yujiro
    Ando, Masahiro
    Yoshimura, Akiko
    Yuan, Jun-Hui
    Fujisaki, Natsumi
    Tokashiki, Takashi
    Kanzato, Naomi
    Jonosono, Manabu
    Sueyoshi, Takeshi
    Kanda, Naoaki
    Matsuoka, Hideki
    Okubo, Ryuichi
    Suehara, Masahito
    Matsuura, Eiji
    Takashima, Hiroshi
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [26] Phenotypic characterization of CADASIL patients with the Arg332Cys mutation in the NOTCH3
    Li, Chen-Si
    Wang, Tian-Wei
    Wang, Jie
    Li, Shuai-Hong
    Li, Na
    Wang, Xiao-Shuang
    Fang, Le
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (01)
  • [27] Detecting a Novel NOTCH3 Variant in Patients with Suspected CADASIL: A Single Center Study
    Sanli, Zeynep Selcan
    Anlas, Ozlem
    MOLECULAR SYNDROMOLOGY, 2024, 15 (02) : 89 - 95
  • [28] Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain
    Monet-Lepretre, Marie
    Bardot, Boris
    Lemaire, Barbara
    Domenga, Valerie
    Godin, Ophelia
    Dichgans, Martin
    Tournier-Lasserve, Elisabeth
    Cohen-Tannoudji, Michel
    Chabriat, Hugues
    Joutel, Anne
    BRAIN, 2009, 132 : 1601 - 1612
  • [29] Therapeutic NOTCH3 cysteine correction in CADASIL using exon skipping: in vitro proof of concept
    Rutten, Julie W.
    Dauwerse, Hans G.
    Peters, Dorien J. M.
    Goldfarb, Andrew
    Venselaar, Hanka
    Haffner, Christof
    van Ommen, Gert-Jan B.
    Aartsma-Rus, Annemieke M.
    Oberstein, Saskia A. J. Lesnik
    BRAIN, 2016, 139 : 1123 - 1135
  • [30] The NOTCH3 score: a pre-clinical CADASIL biomarker in a novel human genomic NOTCH3 transgenic mouse model with early progressive vascular NOTCH3 accumulation
    Rutten, Julie W.
    Klever, Roselin R.
    Hegeman, Ingrid M.
    Poole, Dana S.
    Dauwerse, Hans G.
    Broos, Ludo A. M.
    Breukel, Cor
    Aartsma-Rus, Annemieke M.
    Verbeek, J. Sjef
    van der Weerd, Louise
    van Duinen, Sjoerd G.
    van den Maagdenberg, Arn M. J. M.
    Oberstein, Saskia A. J. Lesnik
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2015, 3 : 89